TTD Drug ID: DAP000794

Drug Information
Name	Sulfinpyrazone
Synonyms	KBioSS_001502; IDI1_000090; USAF GE-13; 4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione; Sulfinpirazona; HMS2092K11; 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin; SMR000058991; MolPort-003-666-286; Anturen; EINECS 200-357-4; ()-Sulfinpyrazone; UNII-V6OFU47K3W; Prestwick_455; sulfinpyrazone (SPZ); Nu-Sulfinpyrazone; DivK1c_000090; S9509_FLUKA; AB00052103; 1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione; Anturane; Anturano; G 28,315; G 28315; Spectrum5_000984; NSC75925; KBio1_000090; 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione; DB01138; D013442; Novartis Brand of Sulfinpyrazone; 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-; Prestwick1_000290; BSPBio_000200; Diphenylpyrazone; 4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione; KBio2_006638; Sulfinpirazona [INN-Spanish]; AC-13602; Prestwick0_000290; AC1L1K4Z; BIDD:PXR0096; Sulfoxyphenylpyrazolidin; NCGC00016255-01; CHEMBL832; SBB058184; SPBio_001447; 1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione; CPD000058991; NCGC00023932-04; Apotex Brand of Sulfinpyrazone; Nu-Pharm Brand of Sulfinpyrazone; BRD-A36217750-001-05-6; CAS-57-96-5; 3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-; Spectrum4_000845; SPECTRUM1500554; NCGC00018267-01; HSDB 3396; Sulfinpyrazone (JP15/USP/INN); Novopyrazone; 1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine; NINDS_000090; KBio3_001540; Sulfinpyrazon; Apo-Sulfinpyrazone; (+/-)-SULFINPYRAZONE; HMS1921C09; Enturan; Spectrum2_001324; MLS000028565; 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione; 1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl-3,5-pyrazolidinedione; BPBio1_000220; C23H20N2O3S; Spectrum3_000590; Anturane (TN); Spectrum_001022; Sulfinpyrazone [USAN:INN:JAN]; 1,2-Diphenyl-3,5-dioxo- 4- (2-phenylsulfinylethyl) pyrazolidine; sulfinpyrazone; KBioGR_001449; S9509_SIGMA; KBio2_004070; SPBio_002419; Nu Sulfinpyrazone; Sulfinpyrazine; Prestwick3_000290; BSPBio_002040; 1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin [German]; D00449; 1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione; Sulfoxyphenylpyrazolidine; Anturidin; BRN 0713597; HMS500E12; CID5342; 57-96-5; Sulfinpyrazonum; MLS001074941; Anturanil; CHEBI:9342; WLN: T5VNNV EHJ BR& CR& E2SO&R; KBio2_001502; Prestwick2_000290; C07317; LS-128688; Enturen; Anturan; NSC 75925; Sulfinpyrazonum [INN-Latin]; Nu Pharm Brand of Sulfinpyrazone; SAM002554932; NCGC00023932-03; HMS1568J22; Sulphinpyrazone; Apo Sulfinpyrazone
Indication	Gout			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Uricosuric Agents
CAS Number	CAS 57-96-5
Formular	C23H20N2O3S
PubChem Compound ID	CID 5342.
PubChem Substance ID	SID 9525.
ChEBI	9342;
SuperDrug ATC ID	B01AC12;
SuperDrug CAS ID	000057965;
Target	Multidrug resistance-associated protein 1			Modulator	[2][3][4]
Ref 1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 011556 To Reference
Ref 2	Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2). Drug Metab Dispos. 2008 Apr;36(4):631-40. Epub 2008 Jan 7. To Reference
Ref 3	Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem. 2001 May 11;276(19):15616-24. Epub 2001 Feb 21. To Reference
Ref 4	Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics. 1999 Sep 15;60(3):295-308. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.